HeartSciences (HSCS) Gross Profit (2021 - 2025)

HeartSciences (HSCS) has reported Gross Profit for 5 consecutive years, with $1411.0 the latest figure, recorded in Q4 2025.

• Quarterly Gross Profit changed N/A year-over-year to $1411.0 in Q4 2025, while the trailing twelve-month figure through Apr 2026 was $5021.0 (down 60.18% YoY) and the FY2026 annual result came in at $2551.0, up 3.28% from the prior year.
• Gross Profit grew to $1411.0 in Q4 2025 per HSCS's latest filing, from $1140.0 in the prior quarter.
• Over the last five years, Gross Profit for HSCS reached as high as $10139.0 in Q1 2024 and fell as low as $1140.0 in Q3 2025.
• A 5-year average of $2637.7 and a median of $1807.0 in 2021 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2023 — Gross Profit plunged 36.9% — and 2024, when it jumped 752.02%.
• Year by year, Gross Profit stood at $1728.0 in 2021, then tumbled by 32.64% to $1164.0 in 2022, then jumped by 104.47% to $2380.0 in 2023, then jumped by 326.01% to $10139.0 in 2024, then plunged by 86.08% to $1411.0 in 2025.
• According to Business Quant data, Gross Profit over the past three periods registered $1411.0, $1140.0, and $2470.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.